½ÃÀ庸°í¼
»óÇ°ÄÚµå
1471209
¼¼°èÀÇ ½ÇÇè½Ç ÀÚµ¿È ½ÃÀå : Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2024-2030³â)Lab Automation Market by Product (Equipment, Services, Software), Automation Type (Modular Automation, Total Lab Automation), Application, End User - Global Forecast 2024-2030 |
½ÇÇè½Ç ÀÚµ¿È ½ÃÀå ±Ô¸ð´Â 2023³â 58¾ï 3,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¾ú°í, 2024³â¿¡´Â 62¾ï 9,000¸¸ ´Þ·¯¿¡ À̸¦ Àü¸ÁÀ̸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 8.30%¿¡¼ 2030³â¿¡´Â 102¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
½ÇÇè½Ç ÀÚµ¿È¿¡´Â ½ÇÇè½Ç¿¡¼ ÃÖ¼ÒÇÑÀÇ ÀÎÀû °³ÀÔÀ¸·Î ½ÇÇè ¹× ÀýÂ÷¸¦ ¼öÇàÇÏ´Â ±â¼úÀÇ È°¿ëÀÌ Æ÷ÇԵ˴ϴÙ. ½ÇÇè½Ç¿¡¼ È¿À²¼º, Á¤È®¼º ¹× »ý»ê¼ºÀ» ³ôÀ̱â À§ÇÑ ´Ù¾çÇÑ Ç÷§Æû, ¼ÒÇÁÆ®¿þ¾î ¹× µµ±¸°¡ Æ÷ÇԵ˴ϴÙ. ±× ¸ñÀûÀº ÈçÇÑ ¹Ýº¹ ÀÛ¾÷À» ÀÚµ¿ÈÇÏ°í °úÇÐÀÚ¿Í ¿¬±¸ÀÚµéÀÌ º¸´Ù º¹ÀâÇÏ°í Çõ½ÅÀûÀÎ ÀÛ¾÷¿¡ ÁýÁßÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â °ÍÀÔ´Ï´Ù. ¼ö¹é¸¸ÀÇ ÈÇÐÀû, À¯ÀüÇÐÀû, ¾à¸®ÇÐÀû ½ÃÇèÀ» ½Å¼ÓÇÏ°Ô ¼öÇàÇÏ´Â °í󸮷® ½ºÅ©¸®´×¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÇÇè½Ç ÀÚµ¿È ½ÃÀåÀÇ ¼ºÀåÀÌ À̾îÁö°í ÀÖ½À´Ï´Ù. ¿¬±¸½Ç Àüü¿¡¼ µðÁöÅÐ ±â¼úÀÇ µµÀÔÀÌ ÁøÇàµÊ¿¡ µû¶ó µ¥ÀÌÅÍÀÇ Á¤È®¼º°ú ÀçÇö¼ºÀÌ Á߽õǰí ÀÖ´Â °ÍÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇÏ°í ÀÖ½À´Ï´Ù. ÀÚµ¿ÈµÈ °Ë»ç½Ç ½Ã½ºÅÛÀÇ ¼³Ä¡¿¡ ÇÊ¿äÇÑ Ãʱâ ÅõÀÚ°¡ ³ôÀº °ÍÀÌ ½ÃÀå ¼ºÀåÀÇ ¹æÇØ°¡ µÇ°í ÀÖ½À´Ï´Ù. ½ÇÇè½Ç ÀÚµ¿È ¼Ö·ç¼ÇÀÇ È¿À²¼ºÀ» ³ôÀ̱â À§ÇÑ Ã·´Ü ±â¼úÀÇ Áö¼ÓÀûÀÎ ÅëÇÕÀº ½ÃÀå ¼ºÀå ±âȸ¸¦ âÃâÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù. ½ÇÇè½Ç ÀÚµ¿È ½Ã½ºÅÛÀÇ È¿À²È¿¡ ±â¿©ÇÏ´Â ¸®Äûµå Çڵ鸵 ½Ã½ºÅÛ, ·Îº¿ °øÇÐ, µ¥ÀÌÅÍ ºÐ¼® Åø µîÀÇ ±â¼úÀÇ ÁøÈ´Â Á¤¹Ðµµ¸¦ Çâ»ó½ÃÄÑ, ÀÎÀ§Àû ½Ç¼öÀÇ °¡´É¼ºÀ» Àú°¨½ÃÅ°±â À§ÇØ, ½ÃÀå ¼ºÀåÀÇ ±â¹ÝÀ» ¸¸µé °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÁÖ¿ä ½ÃÀå Åë°è | |
---|---|
±âÁسâ(2023) | 58¾ï 3,000¸¸ ´Þ·¯ |
¿¹Ãø³â(2024) | 62¾ï 9,000¸¸ ´Þ·¯ |
¿¹Ãø³â (2030) | 102¾ï ´Þ·¯ |
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) | 8.30% |
Á¦Ç° ¾×ü¸¦ Á¤È®ÇÏ°Ô Á¶ÀÛÇÏ´Â ÀÚµ¿ ¾×ü Çڵ鷯 ÀÌ¿ë È®´ë
ÀÚµ¿ ¾×ü Çڵ鷯´Â ¾×ü¸¦ Á¤È®ÇÏ°Ô ÀÛµ¿Çϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ½Ã·á Áغñ, ½Ã¾à ÷°¡, Èñ¼® µîÀÇ ÀÛ¾÷¿¡¼ ¼öÀÛ¾÷À» ´ëÆø ÁÙÀÌ°í 󸮷®À» Çâ»ó½ÃÅ°±â À§ÇØ ½ÇÇè½Ç¿¡¼´Â »©³õÀ» ¼ö ¾ø´Â Á¸Àç°¡ µÇ°í ÀÖ½À´Ï´Ù. ÀÚµ¿ Ç÷¹ÀÌÆ® Çڵ鷯´Â ´Ù¾çÇÑ ½ÇÇè½Ç ¿ëµµ¿¡¼ »ç¿ëµÇ´Â ¸¶ÀÌÅ©·ÎÇ÷¹ÀÌÆ®ÀÇ Ã³¸®¸¦ ÀÚµ¿ÈÇÏ´Â ½Ã½ºÅÛÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Ç÷¹ÀÌÆ®¸¦ ¿î¹Ý, º¸°ü, ºÐ·ùÇÏ°í, ÀǾàÇ°°ú °°Àº ³ôÀº 󸮷® ȯ°æ¿¡¼ ¿öÅ©Ç÷ο츦 °£¼ÒÈÇÕ´Ï´Ù. ÀÚµ¿ÈµÈ º¸°ü ¹× ȸ¼ö´Â ½Ã·á¿Í ÈÇÕ¹°À» È¿À²ÀûÀ¸·Î º¸°üÇÏ°í ȸ¼öÇÒ ¼ö ÀÖ´Â ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀÛ¾÷À» ÀÚµ¿ÈÇÔÀ¸·Î½á ½ÇÇè½ÇÀº »ý¹°ÇÐÀû ¶Ç´Â ÈÇÐÀû ½Ã·áÀÇ ¾öû³ ÄÝ·º¼ÇÀ» ´õ¿í È¿À²ÀûÀ¸·Î °ü¸®ÇÏ°í ½Ã·áÀÇ ¹«°á¼ºÀ» ³ôÀÌ°í ÇÊ¿äÇÒ ¶§ ½Å¼ÓÇÏ°Ô ¾×¼¼½ºÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÇÇè½Ç ·Îº¿ ÆÈÀº Àΰ£ÀÇ ÆÈÀÇ ¿òÁ÷ÀÓÀ» ¸ð¹æÇϸç Æ©ºê ĸÇÎ ¹× µðĸÇΰú °°Àº °£´ÜÇÑ ¹Ýº¹ ÀÛ¾÷ºÎÅÍ º¹ÀâÇÑ ÀÛ¾÷¿¡ À̸£±â±îÁö ±¤¹üÀ§ÇÑ ÀÛ¾÷À» ¼öÇà ÇÒ ¼ö ÀÖ½À´Ï´Ù. »ç¿ëÀÚ Á¤ÀÇ°¡ °¡´ÉÇÏ¸ç ´Ù¸¥ ½ÇÇè½Ç ±â¼ú°ú ÅëÇÕÇÏ¿© ¿øÈ°ÇÑ ÀÚµ¿È¸¦ ½ÇÇöÇÕ´Ï´Ù. ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀº ½ÇÇè½Ç ÀÚµ¿ÈÀÇ ¹éº»À¸·Î, ÀÚµ¿È ½Ã½ºÅÛ°ú ÀåºñÀÇ ÅëÇÕ ¹× °ü¸®¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÚµ¿È ¿öÅ©Ç÷ο츦 Á¦¾îÇÏ°í »ý¼ºµÈ ¹æ´ëÇÑ µ¥ÀÌÅ͸¦ ºÐ¼®Çϱâ À§ÇÑ »ç¿ëÀÚ ÀÎÅÍÆäÀ̽º¸¦ Á¦°øÇÕ´Ï´Ù. Å©·Î¸¶Åä±×·¡ÇÇ µ¥ÀÌÅÍ ½Ã½ºÅÛ(CDS)Àº Å©·Î¸¶Åä±×·¡ÇÇ ÀåÄ¡ÀÇ µ¥ÀÌÅ͸¦ °ü¸®ÇÏ°í ºÐ¼®ÇÕ´Ï´Ù. CDS´Â Å©·Î¸¶Åä±×·¡ÇÇ µ¥ÀÌÅÍÀÇ ¼öÁý, ºÐ¼® ¹× º¸°í °úÁ¤À» °£¼ÒÈÇÕ´Ï´Ù.ÀüÀÚ¿¬±¸³ëÆ®(ELN)(ELN)´Â ±âÁ¸ ½ÇÇè ³ëÆ®¸¦ µðÁöÅÐÈÇÑ °ÍÀÔ´Ï´Ù. °úÇÐÀÚµéÀº ½ÇÇè, ÇÁ·Î¼¼½º ¹× °á°ú¸¦ ÀüÀÚ Çü½ÄÀ¸·Î ±â·ÏÇÒ ¼ö ÀÖ¾î º¸´Ù ³ªÀº ¹®¼È¿Í µ¥ÀÌÅÍ °øÀ¯¸¦ ÃËÁøÇÕ´Ï´Ù. ½ÇÇè½Ç Á¤º¸ °ü¸® ½Ã½ºÅÛ(LIMS)Àº »ùÇÃ, ½ÇÇè½Ç »ç¿ëÀÚ, Àåºñ ¹× Ç¥ÁØÀ» °ü¸®ÇÕ´Ï´Ù. Ç°Áú °ü¸®¸¦ º¸ÀåÇÏ°í ½ÇÇè½Ç¿¡¼ »ùÇà ¹× µ¥ÀÌÅÍÀÇ È¿À²ÀûÀÎ È帧À» ÃËÁøÇÕ´Ï´Ù. ÀÓ»ó°Ë»çÁ¤º¸½Ã½ºÅÛ(LIS)Àº LIMS¿Í ¸¶Âù°¡Áö·Î ÀÇ·á ¹× ÀÓ»ó°Ë»ç¿Í °ü·ÃµÈ µ¥ÀÌÅÍÀÇ Ã³¸® ¹× °ü¸®¿¡ ÁßÁ¡À» µÎ°í ÀÖ½À´Ï´Ù. ȯÀÚ °ü·Ã °Ë»ç µ¥ÀÌÅÍÀÇ Á¤¸®, ÀúÀå ¹× °Ë»öÀ» Áö¿øÇÕ´Ï´Ù. °úÇÐÀû µ¥ÀÌÅÍ °ü¸® ½Ã½ºÅÛ(SDMS)Àº ºñ±¸Á¶ÈµÈ °úÇÐÀû µ¥ÀÌÅ͸¦ ¼öÁý, Ä«Å»·Î±×È, °Ë»ö ¹× °øÀ¯ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. µ¥ÀÌÅÍ ¹«°á¼º ¹× ±ÔÁ¦ ¿ä±¸ »çÇ× Áؼö¸¦ Áö¿øÇÕ´Ï´Ù.
ÃÖÁ¾ »ç¿ëÀÚ: »ý¸í°øÇÐ ¹× Á¦¾à ȸ»ç¿¡¼ ¿öÅ©Ç÷θ¦ °£¼ÒÈÇϱâ À§ÇÑ ½ÇÇè½Ç ÀÚµ¿È ¼Ö·ç¼ÇÀÇ ÀáÀç·Â
»ý¸í°øÇаú Á¦¾àȸ»ç´Â ÀǾàÇ° ¹× °³¹ß ÇÁ·Î¼¼½º¸¦ °¡¼ÓÈÇÒ Çʿ伺À» ¹ÙÅÁÀ¸·Î ½ÇÇè½Ç ÀÚµ¿È ¼Ö·ç¼ÇÀÇ µµÀÔ¿¡ Àû±ØÀûÀ¸·Î Âü¿©ÇÏ°í ÀÖ½À´Ï´Ù. ÀÚµ¿È´Â ÈÇÕ¹° ½ºÅ©¸®´×, À¯ÀüüÇÐ, ´Ü¹éÁúüÇÐ ¿¬±¸ µîÀÇ ¿öÅ©Ç÷ο츦 °£¼ÒÈÇÏ¿© ½ÇÇèÀû Å×½ºÆ®¿¡ ÇÊ¿äÇÑ ½Ã°£°ú ÀÚ¿øÀ» Å©°Ô ÁÙÀÌ´Â ³ôÀº 󸮷® ÇÁ·Î¼¼½º¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¶ÇÇÑ ÀÚµ¿È´Â ±ÔÁ¦ ´ç±¹¿¡ ½ÅûÇÏ°í ÀǾàÇ°À» »ó¾÷ÈÇÏ´Â µ¥ Áß¿äÇÑ µ¥ÀÌÅÍÀÇ ÀçÇö¼º°ú ½Å·Ú¼ºÀ» º¸ÀåÇÕ´Ï´Ù. º´¿ø ¹× Áø´Ü ½ÇÇè½ÇÀÇ ÁÖ¿ä ¸ñÀûÀº Àû½Ã¿¡ Á¤È®ÇÑ Áø´Ü °Ë»ç¸¦ ÅëÇØ È¯ÀÚ °ü¸®¸¦ °³¼±ÇÏ´Â °ÍÀÔ´Ï´Ù. ½ÇÇè½Ç ÀÚµ¿È´Â ´ë·®ÀÇ È¯ÀÚ »ùÇà ó¸®, ¼öÀÛ¾÷À¸·Î ÀÎÇÑ ½Ç¼ö °¨¼Ò, ½Å¼ÓÇÑ °á°ú Á¦°ø¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ È¯°æ¿¡¼ÀÇ ÀÚµ¿È ½Ã½ºÅÛ¿¡´Â »ùÇà ºÐ·ù, »ýÈÇÐ ºÐ¼® ¹× ºÐÀÚÁø´ÜÀ» À§ÇÑ Àåºñ°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ Áøº¸´Â ¿öÅ©Ç÷οìÀÇ È¿À²¼ºÀ» °³¼±ÇÏ°í, ´õ ³ªÀº ÀÚ¿ø ¹èºÐÀ» °¡´ÉÇÏ°Ô Çϸç, ½Å¼ÓÇÑ Áø´Ü°ú Ä¡·á¸¦ °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á ȯÀÚ °á°úÀÇ °³¼±¿¡ ±â¿©ÇÕ´Ï´Ù. ¿¬±¸±â°üÀ̳ª Çмú±â°ü¿¡¼´Â ±âÃÊÀûÀÎ »ý¹°Çבּ¸ºÎÅÍ À¯ÀüÇÐÀ̳ª »ý¹°ÀÇÇаøÇÐ µîÀÇ ºÐ¾ß¿¡¼ÀÇ °íµµÀÇ ¿¬±¸¿¡ À̸£±â±îÁö Æø³ÐÀº ¿ëµµ¿¡ ½ÇÇè½Ç ÀÚµ¿È¸¦ È°¿ëÇÏ°í ÀÖ½À´Ï´Ù. ÀÚµ¿È´Â ½ÇÇè Á¶°ÇÀÇ Á¤È®ÇÑ Á¦¾î, °úÇÐ ½ÇÇèÀÇ ÀçÇö¼º Çâ»ó, ¼öµ¿À¸·Î °ü¸®ÇÒ ¼ö ¾ø´Â ´ë±Ô¸ð µ¥ÀÌÅÍ ¼¼Æ® ºÐ¼®À» °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á ÀÌ·¯ÇÑ È°µ¿À» Áö¿øÇÕ´Ï´Ù. ÀÌ´Â Çмú¿¬±¸ÀÇ ¼Óµµ¸¦ °¡¼ÓÈÇÒ »Ó¸¸ ¾Æ´Ï¶ó, ¿¬±¸°á°úÀÇ Áú°ú ½Å·Ú¼ºÀ» ³ôÀÌ°í Ãß°¡ °úÇÐÀÇ Áøº¸¸¦ ÃËÁøÇÕ´Ï´Ù.
Áö¿ªº° ÀλçÀÌÆ®·Â
¾Æ¸Þ¸®Ä«¿¡¼´Â ½ÇÇè½Ç ÀÚµ¿È ½ÃÀåÀÌ °·ÂÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ±× ÁÖ¿ä ¿äÀÎÀº ÷´Ü °Ç° °ü¸® ÀÎÇÁ¶ó, Á¦¾à ȸ»ç ¹× »ý¸í °øÇРȸ»çÀÇ ¿¬±¸ °³¹ß¿¡ ¸¹Àº ÅõÀÚ, Çõ½Å¿¡ ´ëÇÑ °ÇÑ °ü½ÉÀÔ´Ï´Ù. ¹Ì±¹Àº Áø´Ü, â¾à ¹× °Ô³ð ¿¬±¸¿¡¼ ÀÚµ¿È ½Ã½ºÅÛÀÇ ´ë±Ô¸ð µµÀÔÀ¸·Î ¸Å¿ì Áß¿äÇÑ ½ÃÀåÀ¸·Î µÎµå·¯Áö°í ÀÖ½À´Ï´Ù. »ý¸í°úÇÐ ¿¬±¸ÀÇ Á¤ºÎ À̴ϼÅƼºê¿Í ÀÚ±Ý Áö¿øÀº ÀÌ Áö¿ª ½ÃÀå È®´ë¸¦ ´õ¿í °ÈÇÏ°í ÀÖ½À´Ï´Ù. APAC Áö¿ªÀº Á¦¾à ºÎ¹® È®´ë, °Ç° °ü¸® ÀÎÇÁ¶ó ÅõÀÚ Áõ°¡, R&D Á߿伺 Áõ°¡·Î ½ÇÇè½Ç ÀÚµ¿È ½ÃÀå¿¡¼ ±Þ¼ºÀåÇÏ°í ÀÖ½À´Ï´Ù. Áß±¹, ÀϺ», Àεµ µîÀÇ ±¹°¡µéÀÌ ÃÖ÷´ÜÀ» ´Þ¸®°í ÀÖÀ¸¸ç, ½ÇÇè½Ç ÀÚµ¿È ±â¼úÀ» È°¿ëÇÏ¿© ¹æ´ëÇÑ Àα¸ÀÇ ÇコÄÉ¾î ¿ä±¸¿¡ ´ëÀÀÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ ½Å±â¼ú µµÀÔ¿¡ ´ëÇÑ ³ë·Â°ú ÀÇ·áºñ Áõ°¡´Â ½ÃÀåÀ» ÁøÀü½ÃÅ°´Â Áß¿äÇÑ ¿äÀÎÀÔ´Ï´Ù. EMEAÀÇ ½ÇÇè½Ç ÀÚµ¿È ½ÃÀåÀº ´Ù¾çȵǰí ÀÖÀ¸¸ç, ½ÅÈï °æÁ¦ ±¹°¡¿Í ¼±Áø °æÁ¦ ±¹°¡¿¡¼ °ÇÑ Á¸Àç°¨À» º¸¿©ÁÝ´Ï´Ù. À¯·´Àº Á¦¾à ¹× »ý¸í °øÇÐ »ê¾÷ÀÌ ¼³¸³µÇ¾úÀ¸¸ç Á¤ºÎ¿Í ¹Î°£ ¿¬±¸ ¹× Çõ½Å¿¡ ´ëÇÑ ÀÚ±Ý Áö¿øÀÌ Ãæ½ÇÇϱ⠶§¹®¿¡ÀÌ Áö¿ªÀ» À̲ø°í ÀÖ½À´Ï´Ù. Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«´Â °Ç° °ü¸® ¼ºñ½º¿Í ¿¬±¸ ´É·Â °È¿¡ Á¡Á¡ ´õ ÁßÁ¡À» µÎ°í Á¡Â÷ Ãß±¸ÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ ¼ºÀåÀº Áø´ÜÀÇ Á¤È®¼º°ú È¿À²¼ºÀ» Çâ»ó½ÃÅ°´Â ½ÇÇè½Ç ÀÚµ¿ÈÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö±âµµÇÕ´Ï´Ù.
FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ½ÇÇè½Ç ÀÚµ¿È ½ÃÀå Æò°¡¿¡ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ºñÁî´Ï½º Àü·« ¹× Á¦Ç° ¸¸Á·µµ¿Í °ü·ÃµÈ ÁÖ¿ä ÁöÇ¥¸¦ Á¶»çÇÏ°í °ø±Þ¾÷üÀÇ Á¾ÇÕÀûÀÎ Æò°¡¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ ¸é¹ÐÇÑ ºÐ¼®À» ÅëÇØ »ç¿ëÀÚ´Â ÀÚ½ÅÀÇ ¿ä±¸ »çÇ׿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ±â¹ÝÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. Æò°¡¿¡ µû¶ó °ø±Þ¾÷ü´Â ¼º°øÀÇ Á¤µµ°¡ ´Ù¸¥ 4°³ÀÇ »çºÐ¸éÀ¸·Î ºÐ·ùµË´Ï´Ù: Àü¸é(F), Æнº ÆÄÀδõ(P), Æ´»õ(N), »ý¸í(V).
½ÃÀå Á¡À¯À² ºÐ¼®
½ÃÀå Á¡À¯À² ºÐ¼®Àº ½ÇÇè½Ç ÀÚµ¿È ½ÃÀå¿¡¼ °ø±Þ¾÷üÀÇ ÇöȲ¿¡ ´ëÇÑ ÀλçÀÌÆ®ÀÌ ÀÖ´Â »ó¼¼ÇÑ Á¶»ç¸¦ Á¦°øÇÏ´Â Á¾ÇÕÀûÀÎ µµ±¸ÀÔ´Ï´Ù. Àü¹ÝÀûÀÎ ¼öÀÍ, °í°´ ±â¹Ý ¹× ±âŸ ÁÖ¿ä ÁöÇ¥¿¡ ´ëÇÑ °ø±Þ¾÷üÀÇ ±â¿©µµ¸¦ ¸é¹ÐÈ÷ ºñ±³ ¹× ºÐ¼®ÇÔÀ¸·Î½á ±â¾÷ÀÇ ¼º°ú¿Í ½ÃÀå Á¡À¯À² °æÀï¿¡ Á÷¸éÇÏ´Â °úÁ¦¿¡ ´ëÇÑ ÀÌÇظ¦ ±í°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ ºÐ¼®Àº Á¶»ç ´ë»ó ±âÁس⿡ °üÂûµÈ ´©Àû, ´ÜÆíÈÀÇ ¿ìÀ§, ÇÕº´ÀÇ Æ¯Â¡ µîÀÇ ¿äÀÎÀ» Æ÷ÇÔÇÑ ÀÌ ºÐ¾ßÀÇ °æÀï Ư¼º¿¡ ´ëÇÑ ±ÍÁßÇÑ °íÂûÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼¼ºÎ ¼öÁØÀÇ È®´ë¸¦ ÅëÇØ °ø±Þ¾÷ü´Â ´õ ¸¹Àº Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸®°í ½ÃÀå¿¡¼ °æÀï ¿ìÀ§¸¦ Â÷ÁöÇÏ´Â È¿°úÀûÀÎ Àü·«À» °í¾ÈÇÒ ¼ö ÀÖ½À´Ï´Ù.
1. ½ÃÀå ħÅõ: ÁÖ¿ä ±â¾÷ÀÌ Á¦°øÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Á¤º¸¸¦ Á¦½ÃÇÕ´Ï´Ù.
2. ½ÃÀå °³Ã´: À¯¸®ÇÑ ½ÅÈï ½ÃÀåÀ» ±íÀÌ ÆÄ°íµé°í ¼º¼÷ÇÑ ½ÃÀå ºÎ¹®ÀÇ Ä§Åõµµ¸¦ ºÐ¼®ÇÕ´Ï´Ù.
3. ½ÃÀå ´Ù¾çÈ : ½ÅÁ¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ÃÖ±Ù °³¹ß, ÅõÀÚ¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.
4. °æÀï Æò°¡ ¹× Á¤º¸ : ½ÃÀå Á¡À¯À², Àü·«, Á¦Ç°, ÀÎÁõ, ±ÔÁ¦ »óȲ, ƯÇã »óȲ, ÁÖ¿ä ±â¾÷ÀÇ Á¦Á¶ ´É·Â¿¡ ´ëÇÑ Ã¶ÀúÇÑ Æò°¡¸¦ ½Ç½ÃÇÕ´Ï´Ù.
5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ±â¼ú, R&D È°µ¿, ȹ±âÀûÀÎ Á¦Ç° °³¹ß¿¡ ´ëÇÑ ÁöÀû ÀλçÀÌÆ®À» Á¦°øÇÕ´Ï´Ù.
1. ½ÇÇè½Ç ÀÚµ¿È ½ÃÀå ±Ô¸ð¿Í ¿¹ÃøÀº?
2. ½ÇÇè½Ç ÀÚµ¿È ½ÃÀå ¿¹Ãø ±â°£ µ¿¾È ÅõÀÚ¸¦ °í·ÁÇØ¾ß ÇÒ Á¦Ç°, ºÎ¹®, ¿ëµµ ¹× ºÐ¾ß´Â ¹«¾ùÀΰ¡?
3. ½ÇÇè½Ç ÀÚµ¿È ½ÃÀåÀÇ ±â¼ú µ¿Çâ°ú ±ÔÁ¦ ƲÀº?
4. ½ÇÇè½Ç ÀÚµ¿È ½ÃÀå¿¡¼ ÁÖ¿ä °ø±Þ¾÷ü ½ÃÀå Á¡À¯À²Àº?
5. ½ÇÇè½Ç ÀÚµ¿È ½ÃÀå ÁøÀÔ¿¡ ÀûÇÕÇÑ ÇüÅÂ¿Í Àü·«Àû ¼ö´ÜÀº?
[188 Pages Report] The Lab Automation Market size was estimated at USD 5.83 billion in 2023 and expected to reach USD 6.29 billion in 2024, at a CAGR 8.30% to reach USD 10.20 billion by 2030.
Lab automation includes the utilization of technology to perform experiments and procedures in the laboratory with minimal human intervention. It encompasses a variety of platforms, software, and tools to enhance efficiency, accuracy, and productivity in laboratory settings. The purpose is to automate mundane, repetitive tasks, allowing scientists and researchers to focus on more complex and innovative work. Increased demand for high-throughput screening that involves rapidly conducting millions of chemical, genetic, or pharmacological tests is driving the growth of the lab automation market. Growing emphasis on data accuracy and reproducibility with the rising adoption of digital technologies across laboratories is driving the growth of the market. The high initial investment required for setting up an automated laboratory system hampers the market growth. Continuous integration of advanced technologies to improve the efficiency of lab automation solutions is expected to create opportunities for market growth. The evolution of technologies such as liquid handling systems, robotics, and data analytics tools that contribute to the efficiency of lab automation systems improve precision, and reduce the possibilities of human error is expected to create a platform for market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 5.83 billion |
Estimated Year [2024] | USD 6.29 billion |
Forecast Year [2030] | USD 10.20 billion |
CAGR (%) | 8.30% |
Product: Growing usage of automated liquid handlers to manipulate liquids precisely
Automated liquid handlers are designed to manipulate liquids precisely. They are essential in laboratories for tasks such as sample preparation, reagent addition, and dilutions, significantly reducing manual effort and increasing throughput. Automated plate handlers are systems that automate the processing of microplates used in various laboratory applications. They transport, store, and sort these plates, streamlining workflows in high-throughput environments such as drug discovery. Automated storage & retrieval offers a solution for efficiently storing and retrieving samples or compounds. By automating these tasks, labs can manage vast collections of biological or chemical samples more effectively, ensuring better sample integrity and faster access when needed. Robotic arms in labs mimic the movements of a human arm and are capable of performing a wide range of tasks, from simple repetitive actions including, capping and decapping tubes to more complex manipulations. They are customizable and can be integrated with other lab technologies for seamless automation. Software solutions are the backbone of lab automation, enabling the integration and management of automated systems and equipment. They provide the user interface for controlling automation workflows and analyzing the vast amount of data generated. The chromatography data system (CDS) manages and analyzes data from chromatography instruments. CDSs streamline the process of collecting, analyzing, and reporting chromatography data. Electronic lab notebooks (ELN) are digital versions of traditional lab notebooks. They allow scientists to record experiments, processes, and results in an electronic format, fostering better documentation and data sharing. Laboratory information management system (LIMS) manages samples, laboratory users, instruments, and standards. It ensures quality control and facilitates the efficient flow of samples and data through the lab. Laboratory information systems (LIS) are similar to LIMS, focused on the processing and management of data related to medical and clinical laboratories. It helps organize, store, and retrieve patient-related laboratory data. A scientific data management system (SDMS) collects and catalogs unstructured scientific data, making it searchable and shareable. It supports compliance with data integrity and regulatory requirements.
End User: High potential of lab automation solutions across biotechnology & pharmaceutical companies for streamlining workflows
Biotechnology & pharmaceutical companies are at the forefront of adopting lab automation solutions, primarily driven by the need to speed up the drug discovery and development process. Automation helps in streamlining workflows, such as screening of compounds, genomics, and proteomics studies, by enabling high-throughput processes that significantly reduce the time and resources needed for experimental trials. Moreover, automation ensures the reproducibility and reliability of the data, which are critical in regulatory submissions and the commercialization of pharmaceutical products. The primary objective within hospitals & diagnostic laboratory settings is to enhance patient care through timely and accurate diagnostic testing. Lab automation plays a critical role in handling large volumes of patient samples, reducing manual errors, and delivering faster results. Automated systems in these environments include equipment for sample sorting, biochemistry analysis, and molecular diagnostics. These advancements improve workflow efficiency, allow for better resource allocation, and contribute to improved patient outcomes by enabling quicker diagnosis and treatment. Research & academic institutes utilize lab automation for a broad range of applications, from basic biological research to advanced studies in fields including, genetics and biomedical engineering. Automation supports these activities by offering precise control over experimental conditions, improving the reproducibility of scientific experiments, and enabling the analysis of large datasets that would be impractical to manage manually. This not only accelerates the pace of academic research but also enhances the quality and credibility of the findings, promoting further scientific advancements.
Regional Insights
In the Americas, the lab automation market is experiencing robust growth, primarily driven by advanced healthcare infrastructure, significant investment in R&D by pharmaceutical and biotech companies, and a strong focus on innovation. The United States stands out as a pivotal market, owing to its large-scale adoption of automated systems in diagnostics, drug discovery, and genomic research. Government initiatives and funding in life sciences research further fuel the market's expansion in this region. The APAC region is witnessing rapid growth in the lab automation market, attributed to its expanding pharmaceutical sector, rising investments in healthcare infrastructure, and growing emphasis on research and development. Countries including, China, Japan, and India are at the forefront, leveraging lab automation technologies to cater to their vast populations' healthcare needs. The region's commitment to adopting new technologies and increasing healthcare expenditure are key factors propelling the market forward. The lab automation market in EMEA is diversified and has a strong presence in developed and emerging economies. Europe leads in this region, driven by its well-established pharmaceutical and biotech industries and substantial government and private funding for research and innovation. The Middle East and Africa are gradually catching up, with an increasing focus on enhancing healthcare services and research capabilities. The growth in this region is also supported by a growing awareness of the benefits of lab automation in improving diagnostic accuracy and efficiency.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Lab Automation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Lab Automation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Lab Automation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accuris Instruments, Agilent Technologies, Inc., Aurora Biomed Inc., Automata Technologies Limited, Awareness Technology, Inc., Azenta Life Sciences, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biochrom by Harvard Bioscience, Inc., Biohit Oyj, bioMerieux SA, BMG Labtech GmbH, Brooks Automation, Inc., Bruker Corporation, Byonoy GmbH, Cerner Corporation by Oracle Corporation, Corning Incorporated, CTK Biotech, Inc., Danaher Corporation, Dendi, Inc., Dynex Technologies, Inc., Endress+Hauser Group Services AG, Enzo Life Sciences, Inc., Eppendorf SE, F. Hoffmann-La Roche Ltd., Formulatrix, Inc., General Biologicals Corporation, Hamilton Company, Hudson Robotics, Inc., JASCO Corporation, Labguru by Biodata Inc, LabVantage Solutions Inc., LabWare, Inc., LigoLab Information System, Mecademic Robotics, Merck KGaA, Orchard Software Corporation, PerkinElmer Inc., Promega Corporation, QIAGEN GmbH, Rayto Life and Analytical Sciences Co.,Ltd., Siemens AG, Strateos, Inc., Synchron Lab Automation by MolGen, Tecan Trading AG, Thermo Fisher Scientific Inc., Uncountable Inc., and Waters Corporation.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Lab Automation Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Lab Automation Market?
3. What are the technology trends and regulatory frameworks in the Lab Automation Market?
4. What is the market share of the leading vendors in the Lab Automation Market?
5. Which modes and strategic moves are suitable for entering the Lab Automation Market?